SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-017242
Filing Date
2009-03-31
Accepted
2009-03-31 09:01:50
Documents
4
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v144138_10k.htm 10-K 1238423
2 v144138_ex10-11.htm EX-10.11 399088
3 v144138_ex31.htm EX-31 18669
4 v144138_ex32.htm EX-32 6887
  Complete submission text file 0001144204-09-017242.txt   1664540
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526
Type: 10-K | Act: 34 | File No.: 000-51476 | Film No.: 09716106
SIC: 2834 Pharmaceutical Preparations